TimesSquare Capital Management, LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 1 filers reported holding IMMUNOMEDICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TimesSquare Capital Management, LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$116,287,000
+81.2%
1,367,600
-24.5%
1.09%
+77.9%
Q2 2020$64,182,000
+442.2%
1,811,000
+102.9%
0.61%
+482.9%
Q3 2019$11,837,000
-61.9%
892,660
-60.1%
0.10%
-56.1%
Q2 2019$31,063,000
-30.0%
2,239,600
-3.1%
0.24%
-30.1%
Q1 2019$44,379,0002,310,2000.34%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders